SCVA March 2017 Podcast: Transplant Anesthesia: Where We've Been, Where We're Going

03/01/17 • 16 min

Sage Cardiology and Cardiovascular Medicine

Nathaen Weitzel, one of the Editors-in-Chief of SCVA, talks to Ernesto Pretto of The Society for the Advancement of Transplant Anesthesia (SATA). They discuss transplant anesthesia and highlight how Seminars in Cardiothoracic and Vascular Anesthesia will now serve as the official home journal for SATA.

To view the SATA Editorial in the March 2017 issue of SCVA, click here.

To view the SATA Editorial in the March 2017 issue of SCVA, click here.

Previous Episode

SCVA March 2016 Podcast: Cardiopulmonary Bypass Without Heparin

Due to familiarity, short half-life, ease of monitoring, and the availability of a reversal agent, heparin remains the anticoagulant of choice for cardiac operations requiring cardiopulmonary bypass (CPB). However, occasionally patients require CPB but should not receive heparin, most often because of acute or subacute heparin-induced thrombocytopenia (HIT). In these cases, if it is not feasible to wait for the disappearance of HIT antibodies, an alternative anticoagulant must be selected. A number of non-heparin anticoagulant options have been explored. However, current recommendations suggest the use of a direct thrombin inhibitor such as bivalirudin. This review describes the use of heparin alternatives for the conduct of CPB with a focus on the direct thrombin inhibitors.

To view the article, click here.

Next Episode

SCVA March 2017 Podcast: Noteworthy Literature Published in 2016 for Abdominal Organ Transplantation Anesthesiologists: Liver

More than 3000 peer-reviewed publications on the topic of liver transplantation were published in 2016. The goal of this article is to provide a concise review of pertinent literature for anesthesiologists who participate in liver transplantation. The authors selected and presented 33 articles published in 2016 on the topics of MELD policy; cardiovascular, pulmonary, and renal issues; coagulation and transfusion; anesthetic agents; hemodynamic monitors; acute liver failure; and donor issues.

To view the article, click here.